Revenue: The sum of all revenue fields included for a company's operating activities.
Lipella Pharmaceuticals Inc. (LIPO) had Revenue of $0.54M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$0.54M |
$-5.02M |
|
-- |
|
$0.54M |
|
$5.62M |
|
$-5.08M |
|
$0.06M |
|
$-5.02M |
|
$-5.02M |
|
$-5.02M |
|
$-5.02M |
|
$-5.02M |
|
$-5.02M |
|
$-5.08M |
|
$-5.08M |
|
1.05M |
|
1.05M |
|
$-4.79 |
|
$-4.79 |
|
| Balance Sheet Financials | |
$2.62M |
|
$0.01M |
|
$0.06M |
|
$2.67M |
|
$0.75M |
|
-- |
|
-- |
|
$0.75M |
|
$1.92M |
|
$1.92M |
|
$1.92M |
|
1.21M |
|
| Cash Flow Statement Financials | |
$-3.95M |
|
-- |
|
$2.84M |
|
$3.29M |
|
$2.18M |
|
$-1.11M |
|
$0.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-947.23% |
|
-947.23% |
|
-946.69% |
|
-935.25% |
|
-935.25% |
|
$-3.95M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
-- |
|
6.33 |
|
57.65 |
|
-261.34% |
|
-261.34% |
|
-187.60% |
|
-261.34% |
|
$1.59 |
|
$-3.77 |
|
$-3.77 |
|